Ramirez Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.09K Hold
336
﹤0.01% 313
2026
Q1
$9.44K Sell
336
-500
-60% -$13.3K ﹤0.01% 301
2025
Q4
$20.8K Hold
836
﹤0.01% 320
2025
Q3
$21.3K Hold
836
﹤0.01% 323
2025
Q2
$20.3K Sell
836
-184
-18% -$4.29K ﹤0.01% 313
2025
Q1
$25.8K Sell
1,020
-800
-44% -$20.9K 0.01% 317
2024
Q4
$48.3K Hold
1,820
0.01% 299
2024
Q3
$52.7K Sell
1,820
-500
-22% -$14.6K 0.01% 298
2024
Q2
$64.9K Hold
2,320
0.01% 290
2024
Q1
$64.4K Hold
2,320
0.01% 294
2023
Q4
$66.8K Hold
2,320
0.01% 291
2023
Q3
$77K Buy
+2,320
New +$82K 0.02% 280

Other funds holding PFE

Ramirez Asset Management's PFE Position: Q2 2026 in Review

Ramirez Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 336 shares worth $8.09K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

Ramirez Asset Management first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $77K in Q3 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ramirez Asset Management held 336 shares of Pfizer worth $8.09K as of Q2 2026.
  • Ramirez Asset Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Ramirez Asset Management's portfolio in Q2 2026, its #313 holding.
  • Ramirez Asset Management first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • Ramirez Asset Management's Pfizer position peaked at $77K in Q3 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ramirez Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.